logo-loader

Valeo Pharma sees a strong outlook for the company after releasing third quarter financial numbers

Published: 13:52 30 Sep 2020 EDT

Valeo Pharma (CSE: VPH-OTCQB: VPHIF) CEO Steve Saviuk joined Steve Darling from Proactive Vancouver wth news the company has released their 3rd quarter financial numbers that showed lower revenue numbers but Saviuk shared some of the one time events that led to that and also how the slowdown due to the pandemic affected the company. 

Saviuk also told Proactive some of the key milestones the company has hit including a very successful capital raise. Saviuk also talked about the future of Valeo and what he is very excited about moving forward.

Valeo Pharma Q1 numbers shows asthma product revenues increasing by 58%

Valeo Pharma CEO Steve Saviuk joined Steve Darling from Proactive to discuss the company's financial results for the first quarter ended January 31, 2024. Valeo Pharma reported revenues of $13.5 million in Q1-24, compared to $13.1 million in Q1-23 and $13.1 million in Q4-23, representing a 3%...

1 week, 3 days ago